NCT02214654View on ClinicalTrials.gov

A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage

UnknownOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

June 30, 2015

Conditions
Type 2 Diabetes Mellitus；Stable Coronary Disease
Trial Locations (2)

300192

Tianjin First Central Hospital, Tianjin

Tianjin First Central Hospital, Tianjin

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Tianjin Medical University

OTHER